Search

file (14) (1)

Investor Overview

Investor Overview

HOMEInvestor Overview

Read More

2025.Jul.22

News

OBI Pharma Showcases Innovative Pipeline, Platforms, and Technologies at BIO Asia–Taiwan 2025
GlycOBI® and HYPrOBI™ Drive the Advancement of Bispecific, Dual-Payload ADCs

2025.Jun.27

News

Innovation in Action: OBI Pharma Sharpens Focus on ADC Products, Platforms, and Out-Licensing
Integrating Product and Platform Capabilities to Drive Global Collaboration

2025.Jun.10

News

OBI Pharma Showcases Next-Generation ADC Development at 2025 World ADC Asia Summit

Read More

2025.Aug.11

Announcement

Announcement of the Consolidated Financial Statements for the second quarter of 2025 were approved by the Board of Directors

2025.Jul.31

Announcement

Announcement for the expected date of the Board of Directors Meeting for 2025Q2 consolidated financial report is 2025/08/11

2025.Jul.28

Announcement

Announcement on behalf of OBIGEN Pharma of the BOD’s resolution to lift the non-competition restrictions for CEO

2024 Annual Report

Learn how we created value in 2024 and worked to pursue our purpose of enabling a healthier world.

Download PDF
Read More

Featured
Presentation

2025 Investors' Meeting - Innovation in Action

Download PDF

Read More

2025 Annual Shareholders’ Meeting

  • 2025.Jun.27 at 10:00 AM
  • Taipei Bioinnovation Park 1F Conference Room
Youtube

Governance

Read More

Corporate
Overview​

Board of
Directors​

Special ​
Committee​

Integrity​

Internal
Audit​

Governance
Document​

Investor Relations

Contact